Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Invested Capital (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Invested Capital over the past 15 years, most recently at $131.8 million for Q2 2025.

  • For Q2 2025, Invested Capital fell 3.1% year-over-year to $131.8 million; the TTM value through May 2025 reached $131.8 million, down 3.1%, while the annual FY2025 figure was $131.8 million, 3.1% down from the prior year.
  • Invested Capital for Q2 2025 was $131.8 million at Lifecore Biomedical, Inc. \De\, up from $127.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $366.8 million in Q2 2021 and troughed at $75.3 million in Q3 2023.
  • A 5-year average of $177.1 million and a median of $135.0 million in 2023 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: crashed 57.34% in 2023 and later surged 68.7% in 2024.
  • Year by year, Invested Capital stood at $279.6 million in 2021, then crashed by 39.17% to $170.1 million in 2022, then crashed by 44.57% to $94.3 million in 2023, then soared by 34.44% to $126.8 million in 2024, then increased by 3.96% to $131.8 million in 2025.
  • Business Quant data shows Invested Capital for LFCR at $131.8 million in Q2 2025, $127.2 million in Q1 2025, and $126.8 million in Q4 2024.